1 Min Read
Oct 12 (Reuters) - Infant Bacterial Therapeutics AB :
* Names Daniel Mackey as Chief Financial Officer from Jan. 2017
* Mackey replaces Michael Owens in this role Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.